AbbVie Inc. (ABBV) Cash flow statement
Top 10 of 23 line items reported by ABBV · 250+ in the full API →
AbbVie Inc. (ABBV) · Cash Flow Statement
Consolidated Statements of Cash Flows
Quarterly · In millions USD, except per-share data · Latest filed Nov 3, 2026 · FY ends Dec 31
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Trend | |
| Net Cash Flow from Operating Activities | $7,606 | $3,436 | $3,829 | $5,218 | $7,024 | |
| Net Income | 4,218 | 3,613 | 695 | 1,816 | 186 | |
| Net Cash Flow from Investing Activities | $(10,215) | $(1,197) | $(574) | $(1,463) | $(3,264) | |
| Capital Expenditures | -301 | -322 | -265 | -329 | -381 | |
| Other Investing Activities | (-946) | -51 | -43 | -14 | -81 | |
| Net Cash Flow from Financing Activities | $6,820 | $(5,054) | $919 | $(4,166) | $(4,590) | |
| Common stock repurchased | -5 | -9 | -1,489 | -3 | -4 | |
| Other financing activities | (87) | 25 | 2 | (102) | 100 | |
| Net Cash Flow | $4,205 | $(2,822) | $4,162 | $(400) | $(838) | |
| Free Cash Flow | 7,305 | 3,114 | 3,564 | 4,889 | 6,643 | |
Quarterly figures are derived from year-to-date filed amounts.
13 more line items available via the API
Depreciation & AmortizationStock-Based CompensationAccounts receivableInventoriesOther current assetsAccounts payableNet Debt Issued (Repaid)Total debt issuedShort-term debt issuedLong-term debt issuedTotal debt repaidShort-term debt repaidLong-term debt repaid